These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 29556340)

  • 1. The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.
    Huang K; Fang C; Yi K; Liu X; Qi H; Tan Y; Zhou J; Li Y; Liu M; Zhang Y; Yang J; Zhang J; Li M; Kang C
    Theranostics; 2018; 8(6):1540-1557. PubMed ID: 29556340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTRF/CAVIN1, regulated by SHC1 through the EGFR pathway, is found in urine exosomes as a potential biomarker of ccRCC.
    Zhao Y; Wang Y; Zhao E; Tan Y; Geng B; Kang C; Li X
    Carcinogenesis; 2020 May; 41(3):274-283. PubMed ID: 31605605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBE2O ubiquitinates PTRF/CAVIN1 and inhibits the secretion of exosome-related PTRF/CAVIN1.
    Cen X; Chen Q; Wang B; Xu H; Wang X; Ling Y; Zhang X; Qin D
    Cell Commun Signal; 2022 Nov; 20(1):191. PubMed ID: 36443833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of the invasive potential of glioblastoma and expression of caveola-forming proteins caveolin-1 and CAVIN1.
    Pu W; Nassar ZD; Khabbazi S; Xie N; McMahon KA; Parton RG; Riggins GJ; Harris JM; Parat MO
    J Neurooncol; 2019 Jun; 143(2):207-220. PubMed ID: 30949900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway.
    Gao X; Jiang W; Ke Z; Huang Q; Chen L; Zhang G; Li C; Yu X
    Biochem Biophys Res Commun; 2022 Jan; 586():34-41. PubMed ID: 34826698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
    Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
    Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
    [No Abstract]   [Full Text] [Related]  

  • 8. The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.
    Aguila B; Morris AB; Spina R; Bar E; Schraner J; Vinkler R; Sohn JW; Welford SM
    Cancer Lett; 2019 Oct; 462():33-42. PubMed ID: 31377205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EMP1 regulates cell proliferation, migration, and stemness in gliomas through PI3K-AKT signaling and CD44.
    Wang J; Li X; Wu H; Wang H; Yao L; Deng Z; Zhou Y
    J Cell Biochem; 2019 Oct; 120(10):17142-17150. PubMed ID: 31111534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
    Jin T; Li D; Yang T; Liu F; Kong J; Zhou Y
    Oncol Rep; 2019 Aug; 42(2):717-725. PubMed ID: 31173266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.
    Guo Q; Guan GF; Cheng W; Zou CY; Zhu C; Cheng P; Wu AH
    CNS Neurosci Ther; 2019 Mar; 25(3):343-354. PubMed ID: 30311408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LIN28 is involved in glioma carcinogenesis and predicts outcomes of glioblastoma multiforme patients.
    Qin R; Zhou J; Chen C; Xu T; Yan Y; Ma Y; Zheng Z; Shen Y; Lu Y; Fu D; Chen J
    PLoS One; 2014; 9(1):e86446. PubMed ID: 24475120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
    Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL
    PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes as a biomarker platform for detecting epidermal growth factor receptor-positive high-grade gliomas.
    Manda SV; Kataria Y; Tatireddy BR; Ramakrishnan B; Ratnam BG; Lath R; Ranjan A; Ray A
    J Neurosurg; 2018 Apr; 128(4):1091-1101. PubMed ID: 28574310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.
    Yin J; Zeng A; Zhang Z; Shi Z; Yan W; You Y
    EBioMedicine; 2019 Apr; 42():238-251. PubMed ID: 30917935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.
    Kucharzewska P; Christianson HC; Welch JE; Svensson KJ; Fredlund E; Ringnér M; Mörgelin M; Bourseau-Guilmain E; Bengzon J; Belting M
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7312-7. PubMed ID: 23589885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CBX2 Induces Glioma Cell Proliferation and Invasion Through the Akt/PI3K Pathway.
    Wang L; Ren B; Zhuang H; Zhong Y; Nan Y
    Technol Cancer Res Treat; 2021; 20():15330338211045831. PubMed ID: 34709960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.
    Guo D; Reinitz F; Youssef M; Hong C; Nathanson D; Akhavan D; Kuga D; Amzajerdi AN; Soto H; Zhu S; Babic I; Tanaka K; Dang J; Iwanami A; Gini B; Dejesus J; Lisiero DD; Huang TT; Prins RM; Wen PY; Robins HI; Prados MD; Deangelis LM; Mellinghoff IK; Mehta MP; James CD; Chakravarti A; Cloughesy TF; Tontonoz P; Mischel PS
    Cancer Discov; 2011 Oct; 1(5):442-56. PubMed ID: 22059152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner.
    Zhang L; Liu Z; Dong Y; Kong L
    Life Sci; 2021 Jul; 276():119412. PubMed ID: 33774025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.